Multi-Particulate Pellet Technology for Modified-Release Formulations

The Pellet Anatomy

A drug-loaded pellet typically has three layers: an inert starter core (commonly microcrystalline cellulose, "Cellets", or sugar non-pareils); a drug layer applied by spray-coating onto the core with a binder; and a functional coating that controls release. The functional coat is where formulation engineering lives — choice of polymer and thickness determines whether the pellet is immediate-release, enteric-coated, sustained-release, or pulsatile.

Why Pellets, Not Tablets

There are a handful of cases where pellets outperform a conventional tablet on patient outcomes and regulatory robustness:

• Acid-labile drugs (PPIs like Omeprazole, Pantoprazole) — enteric coating protects the API until it reaches the duodenum.
• Drugs with a narrow therapeutic window — multi-particulate dosing reduces peak-trough swings.
• Combination products — different release profiles for each component can be achieved by mixing pellet populations in one capsule.
• Paediatric and geriatric patients — capsules can be opened and sprinkled on food.

Quality Parameters to Specify

When purchasing finished or semi-finished pellets, the parameters that matter most are particle-size distribution (D10/D50/D90), sphericity (aspect ratio ideally >0.9), drug-loading uniformity (RSD <2%), dissolution profile in the relevant media (0.1N HCl for enteric resistance, pH 6.8 buffer for release), and friability after handling. A supplier who cannot provide a release-profile graph for the specific batch is not yet ready to sell into a regulated market.